Abstract
To the Editor.— I read with interest the recent article on the mitral valve prolapse syndrome. 1 One aspect of the syndrome that was not addressed was the use of antiplatelet therapy in patients using the birth control pill. The transient ischemic attacks that I have seen in patients without other forms of organic heart disease have been associated with mitral valve prolapses. In view of this I have recommended antiplatelet therapy in any women using oral contraceptive agents. Since my practice is devoted primarily to cardiology, I am undoubtedly seeing a biased population. However, the unresolved questions are these: should the patients who are being seen by our gynecologic colleagues and beginning use of oral contraceptive agents be screened for mitral valve prolapses, and, if they are found, should they then begin using antiplatelet agents?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
